4/5/2011

Quest Diagnostics has concluded its acquisition of Athena Diagnostics, a former Thermo Fisher Scientific division, for about $740 million. Quest said Athena would continue to operate as an independent business that focuses on the development of diagnostic tests for Alzheimer's disease and other neurological conditions.

Related Summaries